Amplify Weight Loss Drug & Treatment ETF Rating $22.50 +0.52 (+2.37%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.52Holdings in THNR have an aggregate rating of Moderate Buy based on 210 analyst ratings issued in the past year covering 12 companies (69.8% of the portfolio).THNR Aggregate Price Target$22.50High Prediction$22.50Average Prediction$22.50Low Prediction$22.50Holdings in THNR have an aggregate price target of $22.50 and a range of $22.50 to $22.50 covering 12 companies (69.8% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy6 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 12 THNR Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings12.15%LLYEli Lilly and Company$660.41+3.3%4.9985 of 5 stars2.67$964.88 46.1%21Trending NewsEarnings ReportAnalyst ForecastInsider Trade10.43%NVONovo Nordisk A/S$50.90+2.2%4.6795 of 5 stars2.07$83.75 64.5%14Trending NewsEarnings ReportDividend CutAnalyst Upgrade7.27%REGNRegeneron Pharmaceuticals$561.55+0.9%4.9297 of 5 stars2.75$826.91 47.3%24Positive NewsDividend AnnouncementAnalyst Forecast6.93%AMGNAmgen$289.33+1.5%4.6275 of 5 stars2.33$303.76 5.0%21Positive News5.16%MRKMerck & Co., Inc.$82.67+3.0%4.9949 of 5 stars2.35$107.44 30.0%20Positive News5.15%ABBVAbbVie$201.36+1.4%4.7468 of 5 stars2.93$214.95 6.8%27Trending NewsAnalyst Forecast5.13%PFEPfizer$25.14+2.0%4.9898 of 5 stars2.39$28.12 11.8%18Trending News5.03%GILDGilead Sciences$120.14+0.1%4.7117 of 5 stars2.80$114.82 -4.4%25Positive NewsEarnings ReportDividend Announcement4.78%AZNAstraZeneca$77.94+3.5%3.6673 of 5 stars2.80$86.00 10.3%5Positive NewsGap Up3.66%HIMSHims & Hers Health$48.34+0.8%2.7297 of 5 stars1.92$39.83 -17.6%12Trending NewsInsider Trade2.27%VKTXViking Therapeutics$41.27+3.5%4.0749 of 5 stars3.00$86.92 110.6%14Positive News1.86%CRNXCrinetics Pharmaceuticals$30.09+5.7%3.4168 of 5 stars2.78$68.86 128.8%9News CoverageEarnings ReportAnalyst Forecast This page (NYSEARCA:THNR) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access